Knight Therapeutics Inc opened trading today at $5.86 and closed at $5.86. prices ranged from $5.75 to $5.90.

Share prices advanced 1.56% from the previous day's close of $5.77.

During the day across North America, the TSX Composite closed -0.45% at 21642.87, the S&P 500 closed -0.21% at 5051.41, the Dow Jones Industrial Average closed 0.17% at 37798.97 and the Nasdaq Composite closed -0.12% at 15865.25.

Knight Therapeutics Inc traded under GUD on the Toronto Stock Exchange (TSX).

Trading volume was 59,023 on 280 total trades. On average, Knight Therapeutics Inc has traded 67,966 shares over 5 days and 76,098 year-to-date.

The TSX market on the whole today saw 2,131 price advancers against 3,083 declines and 114 unchanged.

During the prior 52 weeks, GUD.TO has traded as high as $5.95 (April 11,2024) and low as $4.35 (October 23,2023). Moreover, in the last 52 weeks, Knight Therapeutics Inc's shares have boosted 21.58%, while in 2024, they have advanced 12.91%.

Following today's trading, Knight Therapeutics Inc has a market capitalization of $583.75 million on a float of 101,170 shares outstanding. Its annual EPS is $-0.16.

Knight Therapeutics Inc is a TSX Drug Specialty & Generic company headquartered in Montreal, CAN.

Currently, Knight Therapeutics Inc has an average recommendation of "Moderate Buy" based on 4.00 analysts according to Zacks. Currently, there are 3 buy ratings and 1 hold ratings for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..